GlassScriptPhysician profile
Robert Burk
NPI 1962095687
$2,509.38
in general payments reported to CMS, 2019-2025
15 companies · $1,856 in 2025
The $1,856 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $235 · 2024: $419 · 2025: $1,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.37 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $926.80 | 2023-2025 | Na, Lcp, Tfn-Advance |
| Stryker Corporation | $700.15 | 2025 | Mako, Gamma, Hoffmann |
| Medical Device Business Services, INC. | $189.88 | 2025 | Dermabond |
| Davol INC. | $188.65 | 2024 | Arista Ah Flexitip |
| Bioventus LLC | $127.39 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Illuminoss Medical, INC. | $80.47 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Si-Bone, INC. | $56.70 | 2025 | |
| Alafair Biosciences, INC. | $47.62 | 2024 | Versawrap |
| Flower Orthopedics Coporation | $45.09 | 2025 | |
| Endo Pharmaceuticals INC. | $38.81 | 2023 | Xiaflex |
| Abbvie INC. | $27.50 | 2023 | Botox |
| Atricure, INC. | $27.15 | 2024 | |
| Heron Therapeutics, INC. | $22.68 | 2025 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $17.53 | 2023 | Iovera, Zilretta, Exparel |
| Mid-Atlantic Surgical Systems, LLC | $12.96 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Burk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.